Growth Metrics

Kiniksa Pharmaceuticals International (KNSA) Amortizatization of Intangibles (2021 - 2025)

Historic Amortizatization of Intangibles for Kiniksa Pharmaceuticals International (KNSA) over the last 5 years, with Q3 2025 value amounting to -$603000.0.

  • Kiniksa Pharmaceuticals International's Amortizatization of Intangibles fell 22381.93% to -$603000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$833000.0, marking a year-over-year decrease of 22359.05%. This contributed to the annual value of -$441000.0 for FY2024, which is 14129.21% down from last year.
  • As of Q3 2025, Kiniksa Pharmaceuticals International's Amortizatization of Intangibles stood at -$603000.0, which was down 22381.93% from $844000.0 recorded in Q2 2025.
  • Kiniksa Pharmaceuticals International's 5-year Amortizatization of Intangibles high stood at $1.2 million for Q2 2023, and its period low was -$1.4 million during Q3 2023.
  • Over the past 5 years, Kiniksa Pharmaceuticals International's median Amortizatization of Intangibles value was -$47000.0 (recorded in 2021), while the average stood at $1631.6.
  • Examining YoY changes over the last 5 years, Kiniksa Pharmaceuticals International's Amortizatization of Intangibles showed a top increase of 161578.95% in 2023 and a maximum decrease of 131092.44% in 2023.
  • Kiniksa Pharmaceuticals International's Amortizatization of Intangibles (Quarter) stood at -$47000.0 in 2021, then surged by 531.91% to $203000.0 in 2022, then surged by 45.81% to $296000.0 in 2023, then tumbled by 376.69% to -$819000.0 in 2024, then rose by 26.37% to -$603000.0 in 2025.
  • Its Amortizatization of Intangibles was -$603000.0 in Q3 2025, compared to $844000.0 in Q2 2025 and -$255000.0 in Q1 2025.